These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8523458)

  • 1. Effect of endothelin-1 and its combination with adenosine on myocardial contractility and myocardial energy metabolism in vivo.
    Beyer ME; Nerz S; Kazmaier S; Hoffmeister HM
    J Mol Cell Cardiol; 1995 Sep; 27(9):1989-97. PubMed ID: 8523458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic and inotropic effects of endothelin-1 in vivo.
    Beyer ME; Nerz S; Krämer BK; Hoffmeister HM
    Basic Res Cardiol; 1994; 89(1):39-49. PubMed ID: 8010934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of endothelin-1 and IRL 1620 on myocardial contractility and myocardial energy metabolism.
    Beyer ME; Slesak G; Nerz S; Kazmaier S; Hoffmeister HM
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S150-2. PubMed ID: 8587348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic and inotropic effects of the endothelin A antagonist BQ-610 in vivo.
    Beyer ME; Slesak G; Brehm BR; Hoffmeister HM
    J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S258-61. PubMed ID: 9595454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of endothelinB receptors for myocardial contractility and myocardial energy metabolism.
    Beyer ME; Slesak G; Hoffmeister HM
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1228-34. PubMed ID: 8819506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo hemodynamic and inotropic effects of the endothelinB agonist IRL 1620.
    Beyer ME; Slesak G; Hoffmeister HM
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S190-2. PubMed ID: 8587359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inotropic effects of endothelin-1: interaction with molsidomine and with BQ 610.
    Beyer ME; Slesak G; Hövelborn T; Kazmaier S; Nerz S; Hoffmeister HM
    Hypertension; 1999 Jan; 33(1):145-52. PubMed ID: 9931095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial and circulatory effects of inosine.
    Hoffmeister HM; Betz R; Fiechtner H; Seipel L
    Cardiovasc Res; 1987 Jan; 21(1):65-71. PubMed ID: 3664538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of inotropic effect of endothelin-1 in vivo.
    Ricou FJ; Murata K; Oh BH; Kambayashi M; Peterson KL
    J Cardiovasc Pharmacol; 1992 Oct; 20(4):671-7. PubMed ID: 1280726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine induced direct negative inotropic effect is abolished during global ischemia: role of protein kinase C and prostacyclin.
    Oriji GK
    Prostaglandins Leukot Essent Fatty Acids; 2000 Dec; 63(6):343-9. PubMed ID: 11133171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of the endothelin ETA receptor in the haemodynamic and inotropic effects of endothelin-1 in rats.
    Beyer ME; Hövelborn T; Delabar U; Hoffmeister HM
    Clin Sci (Lond); 2004 Nov; 107(5):467-75. PubMed ID: 15233620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic effects of cibenzoline on normal myocardium and after pretreatment with DL-sotalol.
    Beyer ME; Hoffmeister HM; Seipel L
    J Cardiovasc Pharmacol; 1992 May; 19(5):657-64. PubMed ID: 1381761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of shenqifuxin oral liquid on the plasma kaliuretic peptide, the myocardial contractility and relaxation of left ventricle and the left ventricular remodeling in experimental rats with heart failure].
    Ma L; Lei Y; Xue Q; Wang SW; Yang DY; Lu ZZ
    Zhongguo Zhong Yao Za Zhi; 2003 Jul; 28(7):656-60. PubMed ID: 15139115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive inotropic and hemodynamic properties of flosequinan, a new vasodilator, and a sulfone metabolite.
    Falotico R; Haertlein BJ; Lakas-Weiss CS; Salata JJ; Tobia AJ
    J Cardiovasc Pharmacol; 1989 Sep; 14(3):412-8. PubMed ID: 2476620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of adenosine on the stimulatory effect of isoprenaline and insulin on myocardial contractility in vivo.
    Law WR; Carney PJ; McLane MP
    Cardiovasc Res; 1991 Feb; 25(2):151-7. PubMed ID: 1742765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative inotropic effect of class-I-antiarrhythmic drugs: comparison of flecainide with disopyramide and quinidine.
    Hoffmeister HM; Hepp A; Seipel L
    Eur Heart J; 1987 Oct; 8(10):1126-32. PubMed ID: 3119341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular effects of endothelin in dogs: positive inotropic action in vivo.
    Kitayoshi T; Watanabe T; Shimamoto N
    Eur J Pharmacol; 1989 Aug; 166(3):519-22. PubMed ID: 2680523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelin-1 causes a biphasic response in systemic vasculature and increases myocardial contractility in conscious rabbits.
    Roberts-Thomson P; McRitchie RJ; Chalmers JP
    J Cardiovasc Pharmacol; 1994 Jul; 24(1):100-7. PubMed ID: 7521473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive inotropic action, natriuresis and atrial natriuretic factor release induced by endothelin in the conscious rat.
    Garcia R; Lachance D; Thibault G
    J Hypertens; 1990 Aug; 8(8):725-31. PubMed ID: 2170512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cardiovascular pharmacology of ICI 170777 ((6RS)-6-methyl-5-(pyrid-4-yl)-3H,6H-1,3,4- thiadiazin-2-one) a novel compound with positive inotropic and vasodilator effects.
    Collis MG; Keddie JR; Rouse W
    Br J Pharmacol; 1989 Jun; 97(2):409-18. PubMed ID: 2758224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.